‘Good’ cholesterol doctrine may be flawed, says study

By Agence France-Presse
Wednesday, May 16, 2012 23:48 EDT
google plus icon
A patient thas her blood pressure checked by a volunteer at a free medical clinic for the uninsured in New Orleans, Louisiana, in August 2010. One in three adults suffers from high blood pressure, a key cause of strokes and heart disease, according to World Health Organisation figures released on Wednesday. (AFP Photo/Mario Tama)
  • Print Friendly and PDF
  • Email this page

PARIS — Researchers on Thursday challenged a tenet of modern medicine that higher levels of “good” cholesterol automatically boost cardiovascular health.

In a study published in The Lancet, investigators said they found no evidence to back the belief that higher levels of high-density lipoprotein (HDL) cholesterol routinely reduce the risk of a heart attack.

High concentrations of HDL are one of the big markers for blood tests.

They are monitored as much as low levels of “bad” cholesterol (low-density lipoprotein, or LDL) as a yardstick of dangerously clogged arteries.

The paper used a method called mendelian randomisation to compare heart-attack risk among people who inherited known genetic variants that gave them higher HDL levels.

According to conventional wisdom, these individuals would have a lower risk of a coronary.

But the study, which looked at nearly 12,500 people with a history of a heart attack and over 41,000 otherwise healthy counterparts, found this was not always the case.

The results are important because of the use of drugs, sometimes inflicting side effects, which are administered to boost HDL cholesterol levels.

“These results show that some ways of raising HDL cholesterol might not reduce risk of myocardial infarction [heart attack] in human beings,” said Sekar Kathiresan of Massachusetts General Hospital and Harvard Medical School.

“Therefore, if an intervention such as a drug raises HDL cholesterol, we cannot automatically assume that risk of myocardial infarction will be reduced.”

In contrast, the study said “bad” cholesterol remained an accurate marker of cardiac risk.

Separately, a study, also carried in Thursday’s Lancet, confirmed the benefits of LDL-lowering statins for protecting people with no previous history of cardiovascular disease.

Agence France-Presse
Agence France-Presse
AFP journalists cover wars, conflicts, politics, science, health, the environment, technology, fashion, entertainment, the offbeat, sports and a whole lot more in text, photographs, video, graphics and online.
By commenting, you agree to our terms of service
and to abide by our commenting policy.